AI sales platform Symbe raises £4.3m led by Kfund with support from Notion Capital
This article covers Symbe, a London-based B2B enterprise software startup, which on 15 October 2026 raised £4.3m in a seed funding round to expand its AI-powered platform that automates the creation of business cases for B2B sales. The development aims to support enterprise sellers and procurement teams by standardising ROI calculations, reducing manual analysis and shortening procurement cycles.
London-based Symbe has raised £4.3m in a seed funding round to expand its AI-powered platform that automates the creation of business cases for B2B sales. The financing underlines investor interest in tools that shorten lengthy, analyst-heavy procurement cycles and help sellers quantify return on investment for enterprise buyers.
Why it matters
Enterprise software procurement still often relies on spreadsheets, bespoke models and manual work by value engineering teams. That friction slows deal cycles and concentrates knowledge in a few specialists. Symbe’s platform targets that bottleneck by standardising how value is calculated and shared between buyers and sellers, which could speed decisions and make large deals easier to replicate across sales teams.
Since launching in 2023, Symbe says more than 2,500 companies have built business cases on its platform. Its customer list includes Salesforce, Stripe, HubSpot, BMC Helix, monday.com, SingleStore and FICO — companies that either sell enterprise software at scale or run complex buying processes themselves. Larger customers frequently start with paid pilot projects before rolling the platform out to additional sales teams.
Inside the product
Symbe ingests inputs such as sales calls, meeting notes, emails and CRM data to generate standardised business cases and ROI calculations. The intention is to move those artefacts out of siloed spreadsheets and into collaborative documents that buyers and sellers can develop together. Technically, the product positions itself at the intersection of sales enablement, revenue operations and procurement analytics, with potential use cases beyond new-business deals — for example, procurement decisions or internal investment appraisals where quantified financial impact is required.
The company says the platform helps reduce manual analysis and applies consistent value-based selling practices across larger sales organisations, which can improve forecasting and shorten negotiation timelines.
Who are the investors?
Symbe’s £4.3m seed round was led by Kfund, with participation from 4Founders Capital, Sure Valley Ventures, CircleRock Capital, Concept Ventures, Pact and Notion Capital. The round was announced on 15 October 2026 and reported as an equity investment.
The investor line-up mixes early-stage VC firms with investors who have previously backed enterprise software and SaaS businesses. Notion Capital, for example, is known for investing in B2B SaaS companies, while the broader group brings a combination of capital and go-to-market experience that Symbe can use as it scales outbound sales and enterprise pilots.
If you're researching potential backers in this space:
- Explore our list of healthtech venture capital firms in the UK
- Browse our directory of healthtech angel investors in the UK
Founder perspective
Symbe was founded in 2023 by Martin Blinder, Thomas Laurbjerg and Xavier Wilders, who have prior experience building and selling enterprise software. The founders have focused on automating the most time-consuming parts of value engineering and making ROI articulation a repeatable part of the sales process rather than a bespoke exercise.
The bigger picture
The deal points to steady investor appetite for startups applying AI to revenue operations and procurement workflows. For UK-founded B2B software companies, a seed round of this size signals confidence that buyers will pay for tools that materially reduce sales friction and improve deal economics. As AI continues to be woven into front-office tooling, expect more investment into products that translate customer interactions into measurable financial outcomes.
London’s role as a hub for enterprise SaaS and AI tooling remains important: cross-border capital and specialist VCs continue to fuel early-stage growth, while enterprise customers both in the UK and internationally provide immediate use cases for productivity and procurement automation.
They've invested in Symbe
Get to know these healthtech investors
| Investors | Investment Focus | Startup Investments | Round Size | Connect |
|---|---|---|---|---|
 Kfund( ) Madrid, Spain | SymbeRiverse | |||
 4Founders Capital( ) | ||||
 Sure Valley Ventures( ) Sure Valley Ventures is a venture capital firm focused on early-stage software e... London, Dublin, Cambridge  | ||||
 CircleRock Capital( ) CircleRock Capital is a European venture capital syndicate that facilitates acce... London | ||||
 Concept Ventures( ) Concept Ventures is the largest dedicated UK pre-seed fund, focusing on reshapin... London | ||||
 Pact( ) Melbourne, Australia | ||||
 Notion Capital( ) Notion Capital is an early-stage venture capital firm that specialises in softwa... London | ||||
| All investors | All investor sectors | All funded startups | All funding rounds |
Click here for a full list of 7,589+ startup investors in the UK